Poster Exhibition 1

[PE-060] Efficacy and safety of subcutaneous guselkumab in East Asian participants with moderately to severely active Crohn’s disease: Subgroup analysis of the Phase 3 GRAVITI study

Wenjia Liu¹, Hong Guo², Tae Oh Kim³, *Ken Takeuchi⁴, Tadakazu Hisamatsu⁵, Jennifer Fable⁶, Mobolaji Olurinde⁶, Brian Wahking⁷, Jianmin Zhuo⁸, Qian Cao⁹ (1. The Second People’s Hospital of Changzhou, the Third Affiliated Hospital of Nanjing Medical University, Changzhou, 213003, China, 2. Chongqing General Hospital, Chongqing University, Chongqing, 400014, China, 3. Department of Internal Medicine, Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea, 4. Director of Gastroenterology, Manager of IBD Centre, Tsujinaka Hospital Kashiwanoha, 146-6 Kashiwanoha Campus, 178-2 Wakashiba, Kashiwa City, Chiba 277-0871, Japan, 5. Department of Gastroenterology and Hepatology, Kyorin University School of Medicine, Tokyo, Japan, 6. Janssen Research & Development, LLC, Spring House, PA, USA, 7. Janssen Asia Pacific, Singapore , 8. Janssen China R&D, Shanghai, China, 9. Sir Run Run Shaw Hospital Affiliated with School of Medicine, Zhejiang University, Hangzhou, China)

Password required to view

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.